ESTRO 2010 - Snapshots from the conference

European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010
ESTRO 2010 - Snapshots from the conference ( European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010 )
25 Oct 2010

ESTRO 2010 Highlights

Professor Gordon McVie - European Institute of Oncology
ESTRO 2010 Highlights ( Professor Gordon McVie - European Institute of Oncology )
6 Oct 2010

Radiation treatment of prostate cancer

Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy
Radiation treatment of prostate cancer ( Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy )
6 Oct 2010

Smart radiotherapy in the treatment of prostate cancer

Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy
Smart radiotherapy in the treatment of prostate cancer ( Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy )
6 Oct 2010

The use of hormone therapy to treat advanced prostate cancer

Dr Heather Payne, University College London, UK
The use of hormone therapy to treat advanced prostate cancer ( Dr Heather Payne, University College London, UK )
29 Sep 2010

Targeted therapy for bone metastases

Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Targeted therapy for bone metastases ( Professor Robert Coleman, Weston Park Hospital, Sheffield, UK )
23 Jul 2010

The role of radiotherapy in the treatment of locally advanced prostate cancer

Prof Malcolm Mason - Cardiff University, Wales
The role of radiotherapy in the treatment of locally advanced prostate cancer ( Prof Malcolm Mason - Cardiff University, Wales )
20 Jul 2010

The impact of radiotherapy on patients with high risk localised prostate cancer

Prof Wendy Parulekar - Queen's University, Canada
The impact of radiotherapy on patients with high risk localised prostate cancer ( Prof Wendy Parulekar - Queen's University, Canada )
20 Jul 2010

The efficacy of denosumab and zoledronic acid as treatment for prostate cancer

Dr Karim Fizazi - Institut Gustave Roussy, France
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer ( Dr Karim Fizazi - Institut Gustave Roussy, France )
8 Jul 2010

Roundup of the 2010 ASCO conference

Prof Gordon McVie - European Institute of Oncology, Milan
Roundup of the 2010 ASCO conference ( Prof Gordon McVie - European Institute of Oncology, Milan )
11 Jun 2010

Metabolic pathway genes and bladder cancer risk

Prof Jie Lin - University of Texas M.D. Anderson Cancer Center, USA
Metabolic pathway genes and bladder cancer risk ( Prof Jie Lin - University of Texas M.D. Anderson Cancer Center, USA )
6 May 2010

BMI, plasma C-peptide and smoking levels predict prostate cancer outcome

Prof Jing Ma - Brigham and Women's Hosptial, Boston, USA
BMI, plasma C-peptide and smoking levels predict prostate cancer outcome ( Prof Jing Ma -  Brigham and Women's Hosptial, Boston, USA )
6 May 2010